Stay updated on AK104+Platinum±Bevacizumab Clinical Trial
Sign up to get notified when there's something new on the AK104+Platinum±Bevacizumab Clinical Trial page.
Latest updates to the AK104+Platinum±Bevacizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.3.2 was added to the page history, and the previous revision v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check21 days agoChange DetectedNew 'Study Status' entry added to the Record History with a 2025-11-19 update, and the version updated to v3.3.1. The earlier version v3.2.0 was removed on 2025-03-04.SummaryDifference0.6%
- Check29 days agoChange DetectedRemoved the site-wide notice about government funding and potential delays, a general informational banner that did not affect study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%
- Check43 days agoChange DetectedRecord History shows updates to recruitment status on 2022-04-26 and 2025-02-28, with a study status change noted on 2025-02-28.SummaryDifference0.1%
- Check72 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference13%
- Check79 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%
Stay in the know with updates to AK104+Platinum±Bevacizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104+Platinum±Bevacizumab Clinical Trial page.